Cargando…
Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
PURPOSE: To demonstrate the role of intravitreal bevacizumab in regression of iris neovascularization, and intraocular pressure (IOP) control in neovascular glaucoma. METHODS: A retrospective random case series study was performed. Twenty eyes of 20 patients who presented with neovascular glaucoma w...
Autores principales: | Marey, Hatem M, Ellakwa, Amin F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130923/ https://www.ncbi.nlm.nih.gov/pubmed/21750619 http://dx.doi.org/10.2147/OPTH.S21453 |
Ejemplares similares
-
Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema
por: Marey, Hatem M, et al.
Publicado: (2011) -
Intracameral bevacizumab and mitomycin C Trabeculectomy for eyes with neovascular glaucoma: a case series
por: de Moraes, Carlos Gustavo Vasconcelos, et al.
Publicado: (2009) -
Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
por: Saeed, Ahmed M, et al.
Publicado: (2014) -
Outcomes of Trabeculectomy With and Without Mitomycin C in Pseudoexfoliative Glaucoma Compared With Mitomycin C in Primary Open Angle Glaucoma
por: LOPES, Ana Sofia, et al.
Publicado: (2019) -
Neovascularization of angle following trabeculectomy augmented with mitomycin-C
por: Shalaby, Wesam Shamseldin, et al.
Publicado: (2021)